Price target
9.410.000.00%
The 17 analysts offering 1 year price forecasts for SAGE have a max estimate of — and a min estimate of —.
Analyst rating
Based on 20 analysts giving stock ratings to SAGE in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
SAGE EPS for the last quarter is −1.53 USD despite the estimation of −1.54 USD. In the next quarter EPS is expected to reach −1.53 USD. Track more of Sage Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Sage Therapeutics, Inc. revenue is expected to reach 14.12 M USD. Check out Sage Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SAGE price target is 9.41 USD with a max estimate of 26.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch Sage Therapeutics, Inc. stock price chart and keep track of the current situation with SAGE news and stock market news.
We've gathered opinions of 20 analysts rating SAGE stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.